In vitro activities of 36 antimicrobial agents against clinically isolated Bacteroides fragilis.
Thirty-six antimicrobial agents were evaluated for in vitro activities against 100 clinical isolates of Bacteroides fragilis. The minimal inhibitory concentration (MIC) of each agent for each isolate was determined by the agar dilution method. Among 25 beta-lactam antibiotics, the most active agent was imipenem with an MIC90 and a geometric mean of 1 and 0.15 micrograms/ml, respectively; followed by ticarcillin-clavulanic acid, and amoxicillin-clavulanic acid. Ampicillin-sulbactam, piperacillin-tazobactam, moxalactam, and flomoxef were the next most active agents. Piperacillin, ticarcillin, ceftizoxime, cefotaxime, cefuzonam, cefoxitin, and cefmetazole were equally active with the MIC50s ranging from 4 to 16 micrograms/ml, and MIC90s ranging from 32 to greater than or equal to 256 micrograms/ml. The remaining 10 beta-lactam antibiotics, ampicillin, amoxicillin, cefazolin, cefuroxime, cefoperazone, cefmenoxime, ceftazidime, cefpirome, aztreonam, and carumonam were less active. All isolates were resistant to cefotiam at a low breakpoint. Among 6 quinolones, ciprofloxacin was the most active agent with an MIC50 and an MIC90 of 4 and 16 micrograms/ml, respectively. All isolates were resistant to nalidixic acid, pipemidic acid, cinoxacin, enoxacin, and norfloxacin. Among 5 frequently used agents, chloramphenicol, ornidazole, and metronidazole were the most effective agents which inhibited 100% of the isolates at 8, 2, and 2 micrograms/ml, respectively; while clindamycin and minocycline had less activity.